Azacitidine + Lenalidomide Combo in the Elderly With Previously Treated AML & High-Risk MDS

Clinical trial NCT01442714 · TERMINATED

Trial details

NCT number: NCT01442714
Sponsor: Stanford University
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia Acute Myeloid Leukemia (AML)Myelodysplastic Syndromes (MDS)

Start date: 2011-08-01
Primary completion: 2014-03-01
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.